With hospitalizations estimated in the hundreds of thousands for influenza, research is more important than ever. Researchers at the Biocomplexity Institute of Virginia Tech’s Nutritional Immunology and Molecular Medicine Laboratory (NIMML) have recently explored a new therapeutic target to treat flu infection.
By re-creating real-world incarceration trends within a computational model, Virginia Tech researchers have created a toolset that can estimate how a set of criminal justice reforms will impact overall rates of imprisonment.
Once thought to affect mainly humans and livestock, Brucella bacteria are now being found in species scientists never expected. Previously unknown strains of the bacteria were recently discovered in African bullfrogs.
Charles W. Steger, president emeritus of Virginia Tech, has been appointed to a three-year term as a member of the Division of Earth and Life Studies (DELS) committee of the National Academy of Sciences. Steger's honor follows closely on the heels of another Biocomplexity Institute affiliate who was named to the National Academy's Social and Behavioral Sciences for National Security Committee, Sallie Keller.
Studying the human immune system is like trying to work a vast, multidimensional jigsaw puzzle with pieces that are constantly changing shape. A recent paper in Trends in Immunology explores how technology is helping scientists arrive at faster, more effective solutions.